Coronary Artery Disease
Radioactive stents: Still in memory?
First published: 19 February 2004
No abstract is available for this article.
REFERENCES
- 1
King SB III.
Restenosis: the mouse that roared.
Circulation
2003;
108:
248–249.
- 2
Hehrlein C,
Gollan C,
Dönges K, et al.
Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits.
Circulation
1995;
92:
1570–1575.
- 3
Wardeh AJ,
Kay IP,
Sabate M, et al.
Beta-particle emitting radioactive stent implantation: a safety and feasibilty study.
Circulation
1999;
100:
1684–1689.
- 4
Serruys PW,
Kay IP.
I like the candy, I hate the wrapper: the 32P radioactive stent.
Circulation
2000;
101:
3–7.
- 5
van der Giessen WJ,
Regar E,
Harteveld MS, et al.
“Edge effect” of 32P radioactive stents Is caused by the combination of chronic stent injury and radioactive dose falloff.
Circulation
2001;
104:
2236–2241.
- 6
Hehrlein C,
Devries JJ,
Arab A, et al.
Failure of a novel balloon-expandable gamma-emitting (103)Pd stent to prevent edge effects.
Circulation
2001;
104:
2358–2362.
- 7
Honda Y,
Grube E,
de la Fuente LM, et al.
Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system.
Circulation
2001;
104:
380–383.
- 8
Hehrlein C,
Fischell TA.
History of the radioisotope stent.
Vasc Radiotherapy Mon
1999;
1:
66–69.
